Desarrollo y validaci??n del Inventario de Perfeccionismo Infantil (I.P.I.)

Existen pocos estudios que relacionen el perfeccionismo infantil con diferentes trastornos, ya sean internalizados o externalizados. Asimismo, en castellano, no existe una escala que mida los diferentes aspectos que lo conforman. En este trabajo se presenta el Inventario de Perfeccionismo Infantil (IPI). La muestra con la que se ha trabajado est?? compuesta por 2.260 participantes (51,2 por ciento varones y 48,8 por ciento mujeres). El rango de edad oscila entre los 8 y los 13 a??os (Media= 9,94 y Desviaci??n t??pica= 1,27). El muestreo se realiz?? de forma aleatorio estratificado. El 78,1 por ciento corresponden a ense??anza p??blica y el 21,9 por ciento a ense??anza privada concertada. El 16,2 por ciento reside en zona rural y el 83,8 por ciento en ??reas urbanas. Para estudiar la validez del cuestionario se emple?? una validaci??n cruzada. Inicialmente se obtuvieron, a trav??s de un an??lisis factorial exploratorio, tres factores: Autovaloraci??n, Autoexigencia y Presi??n externa con unos ??ndices adecuados de fiabilidad (alfa de Cronbach= 0,89, 0,87 y 0,88, respectivamente). Posteriormente, utilizando una metodolog??a confirmatoria se ha comprobado que los tres factores iniciales son explicados por un ??nico factor de segundo orden que se denomina 'Perfeccionismo'.

More appropriate: additional stories for students who are hearing impaired using the "Specialized Program Individualizing Reading Excellence" (S.P.I.R.E.) curriculum

S.P.I.R.E., at use at Central Institute for the Deaf, is a comprehensive, multi-sensory systematic reading and language program that targets at risk and struggling students. The purpose of this project was to write additional stories and sentences for students who are hearing impaired through reader 2 that may be used in conjunction with the exiting stories and supplements.

BnP1, a novel P-I metalloproteinase from Bothrops neuwiedi venom: Biological effects benchmarking relatively to jararhagin, a P-IIISVMP

Snake venom metalloproteinases (SVMPs) have been extensively studied and their effects associated with the local bleeding observed in human accidents by viper snakes. Representatives of P-I and P-III classes of SVMPs similarly hydrolyze extracellular matrix proteins or coagulation factors while only P-III SVMPs induce significant hemorrhage in experimental models. In this work, the effects of P-I and P-III SVMPs on plasma proteins and cultures of muscle and endothelial cells were compared in order to enlighten the mechanisms involved in venom-induced hemorrhage. To reach this comparison, BnP1 was isolated from B. neuwiedi venom and used as a weakly hemorrhagic P-I SVMPs and jararhagin was used as a model of potently hemorrhagic P-III SVMP. BnP1 was isolated by size exclusion and anion-exchange chromatographies, showing apparent molecular mass of approximately 24kDa and sequence similarity with other members of SVMPs, which allowed its classification as a group P-I SVMP. The comparison of local effects induced by SVMPs showed that BnP1 was devoid of significant myotoxic and hemorrhagic activities and jararhagin presented only hemorrhagic activity. BnP1 and jararhagin were able to hydrolyze fibrinogen and fibrin, although the latter displayed higher activity in both systems. Using HUVEC primary cultures, we observed that BnP1 induced cell detachment and a decrease in the number of viable endothelial cells in levels comparable to those observed by treatment with jararhagin. Moreover, both BnP1 and jararhagin induced apoptosis in HUVECs while only a small increase in LDH supernatant levels was observed after treatment with jararhagin, suggesting that the major mechanism involved in endothelial cell death is apoptosis. Jararhagin and BnP1 induced little effects on C2C12 muscle cell cultures, characterized by a partial detachment 24h after treatment and a mild necrotic effect as evidenced by a small increase in the supernatants LDH levels. Taken together, our data show that P-I and P-III SVMPs presented comparable effects except for the hemorrhagic activity, suggesting that hydrolysis of coagulation factors or damage to endothelial cells are not sufficient for induction of local bleeding. (C) 2007 Elsevier Ltd. All rights reserved.

P-I class metalloproteinase from Bothrops moojeni venom is a post-proline cleaving peptidase with kininogenase activity: Insights into substrate selectivity and kinetic behavior

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin

Drug-induced liver injury (DILI) is a main cause of drug withdrawal. A particularly interesting example is flucloxacillin (FLUX)-DILI, which is associated with the HLA-B*57:01 allele. At present, the mechanism of FLUX-DILI is not understood, but the HLA association suggests a role for activated T cells in the pathomechanism of liver damage. To understand the interaction among FLUX, HLA molecules, and T cells, we generated FLUX-reacting T cells from FLUX-naive HLA-B*57:01(+) and HLA-B*57:01(-) healthy donors and investigated the mechanism of T cell stimulation. We found that FLUX stimulates CD8(+) T cells in two distinct manners. On one hand, FLUX was stably presented on various HLA molecules, resistant to extensive washing and dependent on proteasomal processing, suggesting a hapten mechanism. On the other hand, in HLA-B*57:01(+) individuals, we observed a pharmacological interaction with immune receptors (p-i)-based T cell reactivity. FLUX was presented in a labile manner that was further characterized by independence of proteasomal processing and immediate T cell clone activation upon stimulation with FLUX in solution. This p-i-based T cell stimulation was restricted to the HLA-B*57:01 allele. We conclude that the presence of HLA-B*57:01 drives CD8(+) T cell responses to the penicillin-derivative FLUX toward nonhapten mechanism.

Pharmacological interaction of drugs with immune receptors: the p-i concept

Drug-induced hypersensitivity reactions have been explained by the hapten concept, according to which a small chemical compound is too small to be recognized by the immune system. Only after covalently binding to an endogenous protein the immune system reacts to this so called hapten-carrier complex, as the larger molecule (protein) is modified, and thus immunogenic for B and T cells. Consequently, a B and T cell immune response might develop to the drug with very heterogeneous clinical manifestations. In recent years, however, evidence has become stronger that not all drugs need to bind covalently to the MHC-peptide complex in order to trigger an immune response. Rather, some drugs may bind directly and reversibly to immune receptors like the major histocompatibility complex (MHC) or the T cell receptor (TCR), thereby stimulating the cells similar to a pharmacological activation of other receptors. This concept has been termed pharmacological interaction with immune receptors the (p-i) concept. While the exact mechanism is still a matter of debate, non-covalent drug presentation clearly leads to the activation of drug-specific T cells as documented for various drugs (lidocaine, sulfamethoxazole (SMX), lamotrigine, carbamazepine, p-phenylendiamine, etc.). In some patients with drug hypersensitivity, such a response may occur within hours even upon the first exposure to the drug. Thus, the reaction to the drug may not be due to a classical, primary response, but rather be mediated by stimulating existing, pre-activated, peptide-specific T cells that are cross specific for the drug. In this way, certain drugs may circumvent the checkpoints for immune activation imposed by the classical antigen processing and presentation mechanisms, which may help to explain the peculiar nature of many drug hypersensitivity reactions.

Multimetallic complexes based on phosphine- and phosphine oxide- appended p-hydroquinones

Presented here, is the work done with a series of binucleating ligands based on phosphine and phosphine oxide appended p-hydroquinones and their reactions towards various metals sources. The long term goal of the project was to produce coordination polymers that would have novel electronic, magnetic, and optical properties which would be of use in the field of molecular electronics. Binucleating ligands contained a p-hydroquinone motif in which various phosphine- and phosphine oxide substituents have been placed in the ortho position relative to each of the hydroxy position were synthesized. A previously published synthetic method for such lugands utilized n-BuLi to form a phenyl lithium intermediate which was quenched with chlorodiphenylphosphine. This technique was also used to produce a ligand with diisopropylphosphine groups. Phosphine ligands, containing the same structural motif, were also generated using LDA as the lithiating agent. This technique was found to be higher yielding. Phosphine chalcogenide ligands were accessed by further oxidizing the low valent phosphorous centers with either hydrogen peroxide or with elemental sulfur. These ligands were characterized using multinuclear NMR, low and high resolution mass spectroscopy, FTIR, and single crystal X-ray diffraction. Their electrochemical properties were explored with cyclic voltammetry. The phosphine appended ligands were used in the synthesis of a several bimetallic complexes. It was found that the ligands readily reacted with NiCp2 and NiCp*2, displacing one of the cyclopentadiene (Cp) or pentamethylcyclopentadiene (Cp*) rings. A cyclopentadiene complexes, containing diisopropylphine, was readily oxidized by[FeCp2]PF6 to give a NMR silent mixed valence complex. Cyclic voltammetry of these complexes showed a number of reversible waves with a large potential separation. The mixed valence compounds also showed a large absorbance band in the NIR region which was assigned to be an intervalence charge transfer. The cyclic voltammetry and NIR spectroscopy suggest that these systems are very capable of efficient metal-to-metal charge transfer. These complexes were characterized by multinuclear NMR, single crystal X-ray diffraction, UV/VIS-NIR spectroscopy and elemental analysis. The phosphine oxide ligands were reacted with a variety of different metal sources but limited success was gained in obtaining single crystals, allowing structural characterization of these compounds. Single crystals were obtained from products generated by reacting the diphenylphosphine oxide ligand with (Bipy)Cu(NO3)2 and Cu(NO3)2. In all cases the ligand had been further oxidized to a 2,5-dihydroxy-1,4-benzoquinone motif. In the reaction between the diphenylphosphine oxide ligand and (Bipy)Cu(NO3)2 it was found that the phosphine oxide moiety was involved with intermolecular coordination leading to the formation of a one-dimensional polymer composed of a series of bimetallic complexes tethered together. When NaSbF6 was present in the reaction with (Bipy)Cu(NO3)2 a unique tetrametallic complex was formed. Here the phospine oxide moiety was oriented so that two bimetallic complexes were bound together. If only Cu(NO3)2 was present, a two-dimensional polymeric sheet was formed where the ligand was present in two different coordination modes. The electronic properties of these complexes remained to be assessed.

Interaction of small molecules with specific immune receptors: the p-i concept and its consequences

Drugs may stimulate the immune system by forming stable new antigenic complexes consisting of the drug or drug metabolite which is covalently bound to a protein or peptide (hapten-carrier complex). Both, B- and T-cell immunity may arise, the latter directed to hapten modified peptides presented by HLA molecules. Beside this immunological stimulation, drugs can also stimulate the immune system through binding by non-covalent bonds to proteins like immune receptors. This so-called “pharmacological interaction with immune receptors” concept (“p-i concept”) may occur with HLA or TCR molecules themselves (p-i HLA or p-i TCR), and not the immunogenic peptide. It is a type of “off-target” activity of the drug on immune receptors, but more complex as various cell types, cell interactions and functionally different T cells are involved. In this review the conditions which lead to activation of T cells by p-i are discussed: important factors for a functional consequence of drug binding is the location of binding (p-i HLA or p-i TCR); the exact site within these immune receptors; the affinity of binding and the finding that p-i HLA can stimulate the immune system like an allo-allele. The p-i concept is able to solve some puzzles of drug hypersensitivity reactions and are a basis to better treat and potentially avoid drug hypersensitivity reactions. Moreover, the p-i concept shows that in contrast to previous beliefs small molecules do interact with immune receptors with functional consequence. But these interactions are not based on “immune recognition”, are at odds with some immunological concepts, but may nevertheless open new possibilities to understand and even treat immune reactions

Na 1 Nachlass Max Horkheimer, 50 - Korrespondenzen u.a. an die Firma A. L. Stamm & Co (p. I 23, 190-421)

9 Briefe und Beilage zwischen Alfred Sohn-Rethel und Max Horkheimer, 1936-1940 sowie Briefwechsel mit Joan M. Levi; 6 Briefe zwischen Joan M. Levi und Max Horkheimer, 1940; 1 Brief von Max Horkheimer an Assistac Westcent, 25.06.1937; 1 Brief von John MacMurray an Walter Adams, 19.05.1937; 1 Brief von Walter Adams an Theodor W. Adorno, 01.06.1937; 2 Briefe zwischen Charles Somlo & Co und Max Horkheimer, 06.06.1939, 12.09.139; 1 Brief von Martin Sommerfeld an Max Horkheimer, 29.05.1934; 3 Briefe von Josef Sondek an Max Horkheimer, 1937, 1942; 3 Briefe zwischen Elsa Sontheimer, Max Sontheimer und Max Horkheimer, Februar 1940, 07.03.1940; 1 Drucksache von der The Southard School an Max Horkheimer; 1 Brief von der Soziologischen Verlagsanstalt an Gertrud Janosi, 20.07.1931; 9 Briefe zwsichen Maurice J. Speiser und Max Horkheimer, 1936-1948; 2 Briefe zwischen de Spengler und Max Horkheimer, 30.11.1936, 27.01.1937; 5 Briefe zwischen Sterling D. Spero und Max Horkheimer, 1936-1937; 1 Lebenslauf von Herbert Spielberg; 1 Brief und 2 Beilagen von René A. Spitz an Max Horkheimer, 23.06.1938; 2 Briefe von Elsa Spriesterbach an Max Horkheimer, Juli 1949; 1 Brief von Ida M. Stadie an Max Horkheimer, 21.05.1937; 20 Rechnungen von A. L. Stamm & Co an Max Horkheimer, 1938-1939; 1 Brief von Rose Horkheimer an A. L. Stamm und Co, 28.09.1938; 1 Betriebsanleitung und 1 Auslieferugnsschein für Max Horkheimer vom Standard Air Conditioning, 03.03.1936; 1 Brief von Max Horkheimer an Standard Air Conditioning, 28.03.1936; 5 Briefe zwischen Taylor Starck und Max Horkheimer, 1943; 8 Briefe zwischen Hans Staudinger und Max Horkheimer, 1937, 1943; 1 Briefauszug und Beilage von Paul Stefan, 1940 sowie Briefwechsel mit Samuel R. Wachtell; 1 Brief von Samuel R. Wachtell an Gertrude Blitz, 23.10.1940; 3 Briefe zwischen Leo Löwenthal und Samuel R. Wachtell, September 1940, 23.10.1940; 1 Brief von Loe Löwenthal an Hermann Kesten, 01.10.1940; 7 Briefe und Beilage zwischen George Stefansky und Max Horkheimer, 1939-1940; 2 Briefe zwischen dem Refugee Section of the American Friends Service Committee und Max Horkheimer, 16.05.1940, 28.05.1940; 3 Briefe zwischen dem Institute of International Education und Max Horkheimer, 09.04.1940, April 1940; 1 Brief von Max Horkheimer an Friess, 01.03.1940; 1 Brief vom Institute of Sociology Malvern und Max Horkheimer, 31.01.1940; 3 Briefe zwischen Stein und Max Horkheimer, 30.11.1934, 1936, 1937; 7 Briefe von Estell A. Stein an Max Horkheimer, 1929, 1937; 1 Brief von Franz Stein an Max Horkheimer; 1 Brief von Friedrich Pollock an Gertrude R. Stein, 22.03.1939; 1 Brief von Leo Stein an Max Horkheimer, 25.07.1944; 1 Brief von Max Horkheimer an Emilia Steinacher, 20.07.1937; 4 Briefe zwischen Friedrich Steinfeld und Max Horkheimer, 1941, 1945; 1 Brief und Beilage von Eugene G. Steinhof an Max Horkheimer; 3 Briefe zwischen Ernst Steinitz und Max Horkheimer, 25.04.1938, April 1938; 2 Briefe zwischen Theodor Steltzer und Eric E. Warburg, 07.03.1948; 4 Brief zwischen Hermine Sterler und Max Horkheimer, 11.09.1939, 1939, 1941; 4 Briefe zwischen Alfred K. Stern und Max Horkheimer, 1938, 1940 sowie 1 Brief und 1 Beilage von Max Gottschalk; 1 Brief von Max Gottschalk an Max Horkheimer; 2 Briefe und 1 Beilage zwischen Erich Stern und Max Horkheimer, 26.02.1937, 17.03.1937; 2 Briefe und Beilage von Eugene I. Stern an Max Horkheimer, 1938; 2 Briefe zwischen Joseph M. Weidberg und Max Horkheimer, 15.07.1938, 29.07.1938; 1 Brief von Max Horkheimer an das Cooperative Bureau for Teachers, 03.02.1938; 12 Briefe zwischen Günther Stern und Max Horkheimer, 1936, 1938 sowie Briefwechsel mit John Guggenheim Memorial Foundation; 3 Briefe und 1 Beilage zwischen der John Simon Guggenheim Memorial Foundation und Max Horkheimer, 1937; 1 Brief vom Social Research Quarterly an Max Horkheimer, 03.01.1937; 3 Briefe zwischen Hugo Stern und Max Horkheimer, 06.12.1937, Dezember 1937;

Na 1 Nachlass Max Horkheimer, 58 - Korrespondenzen u.a. mit Betty Drury (p. I 27, 186-333)

5 Briefe zwischen Konrad Wittwer und Max Horkheimer, 1936, 1938, 1939; 1 Brief von Max Horkheimer an Joseph Wohl, 18.08.1934; 1 Brief von Max Horkheimer an Hedwig Wollenberger, 25.02.1941; 2 Briefe zwischen Richard Wolf und Max Horkheimer, 22.10.1938, 07.11.1938; 2 Briefe zwischen Martha Wolfenstein und Max Horkheimer, 11.10.1937, 19.10.1937; 1 Brief von Clemy Wolff an Leo Löwenthal, 05.03.1941; 2 Briefe zwischen Ilse Wolff und Max Horkheimer, 29.08.1937, 03.09.1937; 1 Brief von Max Horkheimer an Howard Woolston, 25.03.1941; 1 Einladung von der Women's Conference, 1935; 1 Brief von Max Horkheimer an die Women's Conference, 15.03.1935; 1 Brief von der World Foundation an Max Horkheimer, 26.11.1937; 2 Briefe vom World Jewish Congress an Max Horkheimer, 1942, 1945; 1 Brief von Max Horkheimer an Francis Henry Russel, 28.09.1942; 1 Brief von Max Horkheimer an Dr. Opie, 28.09.1942; 1 Brief der Württembergische Hypothekenbank an Max Horkheimer, 24.12.1930; 12 Briefe zwischen Rösle Wuestholz und Max Horkheimer, 1935-1937, 1939; 1 Brief von Max Horkheimer an Frida Wunderlich, 22.11.1937; 1 Brief von Max Horkheimer an die Yale University Library, 22.12.1938; 2 Briefe zwischen Owen D. Young und Max Horkheimer, 22.04.1940, April 1940; 3 Briefe zwischen Hans Zeisel und Max Horkheimer, 21.07.1941, 1941, 1944; 2 Briefe zwischen der Zentrale Hilfsstelle für deutsche Flüchtlingskinder Prag und Max Horkheimer, 01.03.1938, 25.04.1938; 6 Briefe zwischen Gregory Zilboorg und Max Horkheimer, 1939; 16 Briefe und Beilage an Max Horkheimer und F. Pollock von Edgar Zilsel, 1939-1942; 1 Brief vom Social Science Research Counsil an Edgar Zilsel, 01.04.1940; 1 Brief von The Rockefeller Foundation an Edgar Zilsel, 20.06.1939; 9 Briefe und Beilage von Max Horkheimer und F. Pollock an Edgar Zilsel, 1939-1942 sowie Briefwechsel mit Betty Drury; 10 Briefe zwischen The Rockefeller Foundation und Max Horkheimer, 1939-1940; 1 Brief von Max Horkheimer an Edgar Zilsel, 20.06.1939; 12 Briefe zwischen Betty Drury und F. Pollock, 1939-1940; 7 Briefe zwischen Alexander Zinnemann und Max Horkheimer, 1936;

Na 1 Nachlass Max Horkheimer, 28 - Korrespondenzen mit u.a. Siegfried Kracauer (p. I 14, 115-368)

95 Briefe und Beilagen zwischen Siegfried Kracauer und Max Horkheimer, 1936-1949; 2 Briefe zwischen Else Staudinger vom American Committee for Refugee Scholars, Writers and Artists New York und Max Horkheimer, 10.07.1945, 24.07.1945; 2 Briefe zwischen Meyer Schapiro und Siegfried Kracauer 19.11.1937, 03.12.1937; 2 Briefe von Leo Löwenthal an Schapiro Meyer, 1940, 1941; 1 Brief und 1 Beilage von Max Horkheimer an A. Schütz, 02.08.1940; 1 Brief von Max Horkheimer an Trude Krautheimer, 30.07.1940; 1 Brief von Max Horkheimer an das Hebrew Sheltering and Immigrant Aid New York, 10.06.1940; 2 Briefe ziwschen dem Department of State Washington und Max Horkheimer, 05.04.1939, 1939; 2 Briefe zwischen Betty Drury Max Horkheimer, 05.11.1938, 07.11.1938; 2 Briefe zwischen Margaret Krafft und Max Horkheimer, 1938, 1939; 1 Brief von Gertrud Kurth-Kieslinger an Max Horkheimer, 02.10.1939; 2 Briefe zwischen Werner Kraft und Max Horkheimer, 19.01.1940, 01.03.1940; 1 Brief und 1 Beilage von Friedrich Krause an Max Horkheimer, 05.01.1939; 2 Briefe zwischen Karl Krayl und Max Horkheimer, 201.10.1937, 25.11.1937; 11 Briefe zwischen Ernst Krenek und Max Horkheimer, 1937-1941; 1 Brief von S. Krezel an Max Horkheimer, 12.02.1936; 1 Brief von Charles I. Krieger an Max Horkheimer, 01.08.1940; 1 Brief von H. Kronstein an Max Horkheimer, 20.05.1935; 3 Briefe zwischen Germaine Krull und Max Horkheimer, 1934, 06.09.1937, 1937; 3 Briefe zwischen Lawrence S. Kubie Sekretär der American Psychoanalytic Association, New York und Max Horkheimer, 11.05.1938, 1938; 5 Briefe und Beilagen zwsichen Julius Kühl und Max Horkheimer, 18.10.1939-1940; 1 Brief von Max Horkheimer an Herr Guggenheim, 20.02.1940; 1 Brief von Julius Kühl an die ESKA, 31.03.1945; 4 Briefe zwischen B. Kugelmann und Max Horkheimer, 1934, 1938, 1939; 1 Brief von Georg Kunzel an Max Horkheimer, 01.08.1930;

Na 1 Nachlass Max Horkheimer, 6 - Korrespondenzen u.a. mit Célestin Bouglé (p. I 3, 188-402)

66 Briefe zwischen Célestin Bouglé, C. Bouglé, Jeanne Bouglé und Max Horkheimer, 1933-1940; 2 Briefe von Henri Bergson an Célestin Bouglé, 1933, 1935; 1 Brief von Bouvier & Beale an Max Horkheimer, 19.08.1936; 8 Briefe zwischen C. M. Bowra und Max Horkheimer, 1936-1937; 13 Briefe zwischen Ralph Raoul Boyer und Max Horkheimer, 1943-1946; 1 Brief von Max Horkheimer an Justice Louis Brandeis, 18.06.1940; 1 Brief von Karl Brandt von der Notgemeinschaft Deutscher Wissenschaftler im Ausland New York an Max Horkheimer, 27.11.1935; 4 Briefe zwischen Alfred Braunthal und Max Horkheimer, 03.08.1938, 1936-1938; 1 Brief von Trude Briess an Max Horkheimer, 07.06.1938; 4 Briefe zwsichen Lilly Brill und Max Horkheimer, 1947-1948; 1 Brief von Max Horkheimer an Chandis H. Brauchler, 03.09.1949; 1 Brief von Max Horkheimer an Lilian Broadwin, 07.03.1939; 4 Briefe zwischen Lola Bronstein und Max Horkheimer, 1940; 1 Brief von Ferdinand Bruckner an Max Horkheimer, 02.02.1938; 6 Briefe zwischen Paul Bruell udn Max Horkheimer, 1939; 1 Brief von H. Brungs an Max Horkheimer, 20.07.1949; 2 Briefe zwischen Fritz Brupbacher und Max Horkheimer, 31.03.1940, 17.04.1940; 4 Briefe zwischen Gerhard Bry und Max Horkheimer, 1937-1940, 26.01.1940; 1 Brief von Max Horkheimer an Richard Büchner, 29.06.1937; 2 Briefe zwischen Erika Buhlmann und Max Horkheimer, 1949; 13 Briefe zwischen Else Buki und Max Horkheimer, 1940-1941; 1 Brief von Max Horkheimer an Hans Buki, 14.07.1943; 1 Brief von Max Horkheimer an Friedrich Burschell, 29.08.1938; 7 Briefe und 5 Entwürfe zwischen dem Präsident der Columbia University Nicholas Murray Butler und Max Horkheimer, 1938-1941; 1 Brief von Max Horkheimer an Pierce Butler, 03.05.1938;

Na 1 Nachlass Max Horkheimer, 3 - Korrespondenzen u.a. mit Julius S. Bach (p. I 2, 1-130)

33 Briefe zwischen Julius S. Bach und Max Horkheimer, 1937-1941; 1 Brief von Julius S. Bach an Mary von Meldelsohn, 28.08.1940; 24 Briefe zwischen Richard Bach und Max Horkheimer, 1938-1940; 1 Abschrift eines Briefes von Oscar W. Gross an Emil de Leuw, 1938; 1 Brief von A. Bailer an Mr. Iggersheimer, 01.05.1940; 1 Brief von Max Horkheimer an Bailliere, Tindall & Cox London, 05.07.1949; 1 Brief von Beatrix Baird an Max Horkheimer; 5 Briefe zwischen Leonard Balet und Max Horkheimer, 1938-1949; 2 Briefe zwischen John Simon Guggenheim Memorial Foundation New York und Max Horkheimer, 22.11.1948, 05.01.1949; 1 Brief von W. H. de Graaff, Ladislaus Bálint an Max Horkheimer, 11.05.1938; 6 Briefe zwischen Bank of Manhattan Company New York und Max Horkheimer, 1934-1935; 6 Briefe zwischen Ladislaus Bálint und Max Horkheimer, 1934-1935; 2 Briefe zwischen der Bank of the Manhatten Company in New York und Max Horkheimer, 14./15.11.1934; 5 Briefe zwischen der Bankers Trust Company und Max Horkheimer, 1934; 1 Brief von R. Bárány an Max Horkheimer, 05.05.1933; 5 Briefe zwischen Hans Baron und Max Horkheimer, 1936; 3 Briefe zwischen Salo W. Baron und Max Horkheimer, 1941-1942, 16.04.1940; 1 Brief zwischen A. Barratt Brown und Max Horkheimer, 01.10.1936;